GLP1R and type 2 diabetes mellitus: While GLP-1 receptor agonists exert positive effects on glycemic control in T2DM patients, they have not yet been shown to have any therapeutic potential for treating cardiac parasympathetic withdrawal and ventricular arrhythmogenesis.